FHIR-based platform unifying fragmented healthcare data and interoperability
b.well runs a data-heavy healthcare interoperability platform built on Kafka, Spark, and dbt—with a tech stack shaped for real-time streaming and transformation at scale. The company is actively adopting FHIR standards while tackling core infrastructure pain points: scaling real-time pipelines, connecting thousands of disparate data sources, and maintaining integrity across systems. Hiring is concentrated in data and senior engineering roles, reflecting a push to deepen platform foundations rather than expand sales.
b.well Connected Health operates a FHIR-compliant platform designed to unify fragmented healthcare data across hospital systems, health plans, and consumer-facing digital tools. The platform integrates with national interoperability networks (Carequality, CommonWell, eHealth Exchange, TEFCA) and provides healthcare organizations with longitudinal patient records, risk stratification models, and consumer-facing care-shopping experiences. Founded in 2015 and headquartered in Baltimore, the company serves mid-sized healthcare organizations and health systems seeking to break down data silos and enable proactive, personalized care delivery.
Kafka, Apache Spark, dbt, Databricks, FastAPI, MongoDB, PostgreSQL, Kubernetes, AWS/GCP/Azure, and FHIR/HL7 standards for healthcare data exchange and real-time pipeline infrastructure.
Real-time health data interoperability, data pipeline infrastructure, predictive risk stratification, clinical rules engines, digital health record transformation, and integration with national healthcare networks.
b.well Connected Health's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.